Scarica l'app Stockscreener
111.18
1.67%
1.83
Dopo l'orario di chiusura:
111.18
Precedente Chiudi:
$109.35
Aprire:
$111
Volume 24 ore:
875.17K
Relative Volume:
1.47
Capitalizzazione di mercato:
$7.38B
Reddito:
$136.86M
Utile/perdita netta:
$-168.69M
Rapporto P/E:
-39.57
EPS:
-2.81
Flusso di cassa netto:
$-113.49M
1 W Prestazione:
+10.95%
1M Prestazione:
+16.40%
6M Prestazione:
+81.25%
1 anno Prestazione:
+112.50%
Intervallo 1D:
$109.01
$113.91
Intervallo di 1 settimana:
$97.97
$113.91
Portata 52W:
$45.91
$113.91
Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile
Nome
Rhythm Pharmaceuticals Inc
Settore
Industria
Telefono
857-264-4280
Indirizzo
222 BERKELEY STREET, BOSTON, MA
Confronta RYTM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RYTM
Rhythm Pharmaceuticals Inc
|
111.18 | 6.99B | 136.86M | -168.69M | -113.49M | -2.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Iniziato | Goldman | Buy |
| 2025-07-07 | Iniziato | Leerink Partners | Outperform |
| 2025-04-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-03-05 | Ripresa | Stifel | Buy |
| 2025-01-02 | Iniziato | Jefferies | Buy |
| 2024-12-20 | Iniziato | Oppenheimer | Outperform |
| 2024-10-21 | Iniziato | Guggenheim | Buy |
| 2024-09-18 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-17 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-05-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-19 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-08-01 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-01-18 | Ripresa | Canaccord Genuity | Buy |
| 2022-08-08 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-08-05 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-06-17 | Reiterato | Needham | Buy |
| 2022-03-02 | Ripresa | Stifel | Buy |
| 2022-02-17 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-12-08 | Iniziato | Wells Fargo | Overweight |
| 2021-11-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-14 | Ripresa | Goldman | Neutral |
| 2021-08-04 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-08-04 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-30 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-01-08 | Iniziato | Goldman | Sell |
| 2019-07-12 | Aggiornamento | Stifel | Hold → Buy |
| 2019-07-08 | Iniziato | Canaccord Genuity | Buy |
| 2019-03-13 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-09-07 | Ripresa | Morgan Stanley | Overweight |
| 2018-06-25 | Reiterato | Needham | Buy |
| 2018-06-15 | Reiterato | Needham | Buy |
| 2017-10-30 | Iniziato | BofA/Merrill | Buy |
| 2017-10-30 | Iniziato | Needham | Buy |
Mostra tutto
Rhythm Pharmaceuticals Inc Borsa (RYTM) Ultime notizie
How resilient is Rhythm Pharmaceuticals Inc. stock in market downturnsQuarterly Performance Summary & Low Risk High Win Rate Picks - newser.com
Will Rhythm Pharmaceuticals Inc. stock benefit from automation2025 Major Catalysts & Weekly Sector Rotation Insights - newser.com
Morgan Stanley Raises Price Target for RYTM to $129 | RYTM Stock News - GuruFocus
Morgan Stanley Raises Price Target on Rhythm Pharmaceuticals to $129 From $122, Keeps Overweight Rating - MarketScreener
How to recover losses in Rhythm Pharmaceuticals Inc. stockEarnings Trend Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Rhythm Pharmaceuticals Inc. reversing from oversold territoryRisk Management & Free Expert Verified Stock Movement Alerts - newser.com
Rhythm Pharmaceuticals Inc. stock trend forecast2025 Market WrapUp & Verified Momentum Stock Watchlist - newser.com
Rhythm Pharmaceuticals stock hits all-time high at 106.72 USD - Investing.com India
Is a relief rally coming for Rhythm Pharmaceuticals Inc. holdersTrend Reversal & Weekly High Conviction Ideas - newser.com
Is Rhythm Pharmaceuticals Inc. stock cheap at current valuationJuly 2025 Final Week & High Accuracy Trade Signal Alerts - newser.com
Rhythm Pharmaceuticals stock hits all-time high at 106.72 USD By Investing.com - Investing.com Nigeria
A peek inside the mind of a pharmaceutical CFO - CFO Brew
Is it too late to sell Rhythm Pharmaceuticals Inc.2025 Dividend Review & Free Community Consensus Stock Picks - newser.com
Is Rhythm Pharmaceuticals Inc. trending in predictive chart modelsTrade Volume Summary & Fast Entry and Exit Trade Plans - newser.com
Using RSI to spot recovery in Rhythm Pharmaceuticals Inc.July 2025 Fed Impact & AI Based Buy and Sell Signals - newser.com
Is Rhythm Pharmaceuticals Inc. (1RV) stock supported by free cash flowWeekly Market Report & Safe Entry Point Identification - newser.com
Is Rhythm Pharmaceuticals Inc. stock dividend yield sustainablePortfolio Value Summary & High Yield Stock Recommendations - newser.com
Rhythm Pharmaceuticals (RYTM) Stock Analysis: A Biotech Powerhouse with 17% Upside Potential - DirectorsTalk Interviews
Long term hold vs stop loss in Rhythm Pharmaceuticals Inc.July 2025 Big Picture & Safe Entry Momentum Tips - newser.com
What analysts say about Rhythm Pharmaceuticals Inc 1RV stockVolatility Index Analysis & Minimize Portfolio Damage with Warnings - earlytimes.in
Should you hold or exit Rhythm Pharmaceuticals Inc. now2025 Top Gainers & Trade Opportunity Analysis - newser.com
What indicators show strength in Rhythm Pharmaceuticals Inc.Weekly Profit Recap & Capital Efficiency Focused Ideas - newser.com
Leo Wealth LLC Has $850,000 Stock Holdings in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Is Rhythm Pharmaceuticals Inc. (1RV) stock a safe buy pre earningsCEO Change & Consistent Growth Equity Picks - newser.com
Rhythm Pharma Stock Gears Up For Its Next Move - inkl
Rhythm Pharmaceuticals (NASDAQ:RYTM) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Is Rhythm Pharmaceuticals Inc. meeting your algorithmic filter criteria2025 Key Lessons & Low Risk High Win Rate Stock Picks - newser.com
Why Rhythm Pharmaceuticals Inc. (1RV) stock could be next leaderWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Rhythm Pharmaceuticals Inc a good long term investmentEconomic Indicators Overview & Low Risk Capital Growth Plans - earlytimes.in
What momentum shifts mean for Rhythm Pharmaceuticals Inc.July 2025 Reactions & Weekly Hot Stock Watchlists - newser.com
Rhythm Pharmaceuticals (RYTM) Stock Analysis: A Biotech Giant with 19.53% Potential Upside - DirectorsTalk Interviews
Will Rhythm Pharmaceuticals Inc. rebound enough to break evenRecession Risk & Verified High Yield Trade Plans - newser.com
Using data tools to time your Rhythm Pharmaceuticals Inc. exitJuly 2025 Macro Moves & Intraday High Probability Alerts - newser.com
Institutional scanner results for Rhythm Pharmaceuticals Inc.Market Volume Report & Fast Exit/Entry Strategy Plans - newser.com
Should You Expect Robust Growth Potential for Rhythm Pharmaceuticals (RYTM) Ahead? - Yahoo Finance
Rhythm Pharmaceuticals Inc Azioni (RYTM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Rhythm Pharmaceuticals Inc Azioni (RYTM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Shulman Joseph | Chief Technical Officer |
Sep 02 '25 |
Sale |
105.30 |
16,781 |
1,767,006 |
8,509 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):